Extracellular-regulated-kinase 5-mediated renal protection against ischemia-reperfusion injury

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 603-608

  Kawakami, Tomoko ^a,c   Park, Sang Won ^b   Kaku, Ryuji ^a,c   Yang, Jay ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Columbia University P and S ^*  (United States)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

ERK5; IR injury; MAPK; Mobility shift; Viral transduction; Western blot

Indexed keywords

EXTRACELLULAR REGULATED KINASE 5A; EXTRACELLULAR REGULATED KINASE 5B; EXTRACELLULAR REGULATED KINASE 5C; EXTRACELLULAR REGULATED KINASE 5T; LENTIVIRUS VECTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG SCREENING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTRON; KIDNEY INJURY; KIDNEY ISCHEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION INJURY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; HEK293 CELLS; HUMANS; KIDNEY; LENTIVIRUS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 7; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPERFUSION INJURY; TRANSFECTION;

LENTIVIRUS;

EID: 84862781067     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.043     Document Type: Article

References (26)

1. Wang X., Tournier C. Regulation of cellular functions by the ERK5 signaling pathway. Cell Signal. 2006, 18:754-760.
2. Roberts O.L., Homes K., Muller J., Cross D.A.E., Cross M.J. ERK5 and the regulation of endothelial cell function. Biochem. Soc. Trans. 2009, 37:1254-1259.
3. Yoshizumi M., Abe J., Tsuchiya K., Berk B.C., Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J. Pharmacol. Sci. 2003, 91:172-176.
4. Yan C., Ding B., Shishido T., Woo C.H., Itoh S., Jeon K.I., Liu W., Xu H., McClain C., Molina C.A., Blaxall B.C., Abe J. Activation of ERK5 reduces cardiac apoptosis and dysfunction via inhibition of a PDE3A-ICER feedback loop. Circ. Res. 2007, 100:510-519.
5. Shishido T., Woo C.H., Ding B., McClain C., Molina C.A., Yan C., Yang J., Abe J.I. Effects of MER5/ERK5 association on small ubiquitin-related modification of ERK5: Implications for diabetic ventricular dysfunction after myocardial infarction. Circ. Res. 2008, 102:1416-1425.
6. Cameron S.J., Itoh S., Baines C.P., Zhang C., Ohta A., Che W., Glassman M., Lee J.D., Yan C., Yang J., Abe J. Activation of Big MAP Kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion. FEBS Lett. 2004, 566:255-260.
7. Lee J.D., Ulevitch R.J., Han J. Primary structure of BMK1: a new mammalian map kinase. Biochem. Biophys. Res. Commun. 1995, 213:715-724.
8. Zhou G., Bao Z.Q., Dixon J.E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 1995, 270:12665-12669.
9. Kato Y., Kravchenko V.V., Taping R.I., Han J., Ulevitch R.J., Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 1997, 16:7054-7066.
10. Suzaki Y., Yoshizumi M., Kagami S., Nishiyama A., Ozawa Y., Kyaw M., Ixawa Y., Kanematsu Y., Tsuchiya K., Tamaki T. BMK1 is activate in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kid. Int. 2004, 65:1749-1760.
11. Urushihare M., Takamatsu M., Shimizu M., Kondo S., Kinoshita Y., Suga K., Kitamura A., Matsuura S., Yshizumi M., Tamaki T., Kawachi H., Kagami S. ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis. Am. J. Physiol. Renal. Physiol. 2010, 298:F167-F176.
12. Dorado F., Velasco S., Esparis-Ogando A., Pericacho M., Pandiella A., Silva J., Lopez-Novoa J.M., Rodriguez-Barbero A. The mitogen-activated protein kinase ERK5 mediates human mesangial cell activation. Nephrol. Dial. Transplant. 2008, 23:3403-3411.
13. Tiscornia G., Singer O., Verma I.M. Production and purification of lentiviral vectors. Nature Protocols A 2006, 241-245.
14. Gusella G.L., Fedorova E., Hanss B., Marras D., Klotman M.E., Klotman P.E. Lentiviral gene transduction of kidney. Hum. Gene Ther. 2002, 13:407-414.
15. Kim M., Chen S.W.C., Park S.W., Kim M., D'Agati V.D., Yang J., Lee H.T. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kid. Int. 2009, 75:809-823.
16. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand. J. Clin. Lab. Invest. 1965, 17:381-387.
17. Abe J.I., Takahashi M., Ishida M., Lee J.D., Berk B.D. C-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase a (BMK1). J. Biol. Chem. 1997, 272:20389-20394.
18. Yan C., Luo H., Lee J.D., Abe J.I., Berk B.C. Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains. J. Biol. Chem. 2001, 276:10870-10878.
19. McCaw B.J., Chow S.Y., Wong E.S.M., Tan K.L., Guo H., Guy G.R. Identification and characterization of mERK5-T, a novel ERK5/Bmk1 splice variant. Gene 2005, 345:183-190.
20. Mikami M., Yang J. ShRNA-mediated selective knock down of NaV1.8 TTX-resistant voltage-gated sodium channel in dorsal root ganglion neurons. Anesthesiology 2005, 103:828-836.
21. Garfin D.E. One-dimensional gel electrophoresis. Methods in Enzymology, vol. 182 1990, 425-441. Academic Press, San Diego. M.P. Deutscher (Ed.).
22. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
23. Carlotti F., Zaldumbide A., Charif H., deKoning E.J., Luider T.M., Hoeben R.C. The 45-kDa form of Pdx-1 does not result from post-translational modifications. Biochem. Biophys. Res. Commun. 2008, 370:225-229.
24. Sarkozi R., Miller B., Pollack V., Feifel E., Mayer G., Sorokoin A., Schramek H. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells. J. Cell Physiol. 2007, 211:88-100.
25. Browne J.A., Pearson A.L., Zahr R.A., Niculescu-Duvaz I., Baines D.L., Dockrell M.E.C. TGF-β activates ERK5 in human renal epithelial cells. Biochem. Biophys. Res. Commun. 2008, 373:440-444.
26. Grande M.T., Lopez-Novoa J.M. Therapeutic relevance of MAP-kinase inhibitors in renal diseases: current knowledge and future clinical perspectives. Curr. Med. Chem. 2008, 15:2054-2070.